RC

Rajesh Chaudhary

Active Director Director DIN 05158732
DIN 05158732 First appointment Dec 2011 Primary industry Pharma
Unlock full profile Investments · shareholding · contact details
Current companies 4 active board seats
Past companies 2 historical roles
Total affiliations 6 Since Dec 2011
Shareholding value •••• Premium profile

About Rajesh Chaudhary

Data last updated:

Rajesh Chaudhary is a Director at Apotekare Lifesciences Private Limited (since 2021), Director at Arihant Ayurveda Foundation (since 2017) and Director at Rajeshwaranand Yogpeeth Foundation (since 2024), and holds 1 more current directorship. The companies operate in Pharma, Healthcare and Consumer Services. The 2 current companies with reported revenue have a combined latest revenue of ₹4.3 Lakh; the largest is Apotekare Lifesciences Private Limited at ₹4 Lakh (FY 2022). Earlier, Rajesh Chaudhary was a Director at Arhat Ayurvedic Science Of Life Private Limited (2011–2019) and Designated Partner at Arihant Ayurvedic Science Of Life Llp (2014–2021).

DIN 05158732
Primary Designation Director
Industry Pharma
First Appointment 15 Dec 2011
Oldest Company Age 10 yrs
Largest company Apotekare Lifesciences Private Limited · ₹4 Lakh (FY 2022)
Combined revenue ₹4.3 Lakh across 2 companies

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director25 Aug 20212021₹4 Lakh (FY 2022)Active
Arihant Ayurveda Foundation U85310HR2016NPL065638
Director10 Feb 20172016₹27,700 (FY 2025)Active
Rajeshwaranand Yogpeeth Foundation U94910HR2024NPL120857
Director22 Apr 20242024Active
Director02 Feb 20242024Active

Previous companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director15 Dec 20112011Strike Off
Designated Partner09 Oct 20142014Active

Explore Director's current and past company associations Uncover their professional journey today!

Directorship timeline

Open interactive timeline →
Apotekare Lifesciences Private Limited
Arihant Ayurveda Foundation
Rajeshwaranand Yogpeeth Foundation
Rajeshwaranand Yog Shala Private Limited
Premium access

Shareholding and investment profile for Rajesh Chaudhary

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Rajesh Chaudhary

Rajesh Chaudhary currently holds 4 directorships: Apotekare Lifesciences Private Limited (Director, since 25 Aug 2021, revenue ₹4 Lakh (FY 2022)); Arihant Ayurveda Foundation (Director, since 10 Feb 2017, revenue ₹27,700 (FY 2025)); Rajeshwaranand Yogpeeth Foundation (Director, since 22 Apr 2024); Rajeshwaranand Yog Shala Private Limited (Director, since 02 Feb 2024).

Rajesh Chaudhary was first appointed on 15 Dec 2011 as Director at Arhat Ayurvedic Science Of Life Private Limited. The most recent appointment on record is 22 Apr 2024 at Rajeshwaranand Yogpeeth Foundation.

The 2 current companies of Rajesh Chaudhary that report revenue have a combined latest revenue of ₹4.3 Lakh: Apotekare Lifesciences Private Limited ₹4 Lakh (FY 2022); Arihant Ayurveda Foundation ₹27,700 (FY 2025).

Rajesh Chaudhary held 2 earlier board appointments: Arhat Ayurvedic Science Of Life Private Limited (Director, 15 Dec 2011 to 12 Apr 2019); Arihant Ayurvedic Science Of Life Llp (Designated Partner, 09 Oct 2014 to 22 Nov 2021).

The current boards of Rajesh Chaudhary's companies include Jatinder Kansal (Apotekare Lifesciences Private Limited), Manish Gupta (Apotekare Lifesciences Private Limited), Manoj Kansal (Apotekare Lifesciences Private Limited), Tejas Kansal (Apotekare Lifesciences Private Limited), Manpreet Kaur Bagga (Arihant Ayurveda Foundation), Sukhwinder Kaur (Arihant Ayurveda Foundation).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available